These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 9482681)

  • 21. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
    Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
    Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years.
    Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.
    Carrieri G; Bonafè M; De Luca M; Rose G; Varcasia O; Bruni A; Maletta R; Nacmias B; Sorbi S; Corsonello F; Feraco E; Andreev KF; Yashin AI; Franceschi C; De Benedictis G
    Hum Genet; 2001 Mar; 108(3):194-8. PubMed ID: 11354629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.
    Ishii K; Tamaoka A; Mizusawa H; Shoji S; Ohtake T; Fraser PE; Takahashi H; Tsuji S; Gearing M; Mizutani T; Yamada S; Kato M; St George-Hyslop PH; Mirra SS; Mori H
    Brain Res; 1997 Feb; 748(1-2):250-2. PubMed ID: 9067471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.
    Heffernan AL; Chidgey C; Peng P; Masters CL; Roberts BR
    J Mol Neurosci; 2016 Nov; 60(3):316-324. PubMed ID: 27498201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females.
    Porrello E; Monti MC; Sinforiani E; Cairati M; Guaita A; Montomoli C; Govoni S; Racchi M
    Eur J Neurol; 2006 Jun; 13(6):639-44. PubMed ID: 16796589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.
    Molero AE; Pino-Ramírez G; Maestre GE
    Neurosci Lett; 2001 Jul; 307(1):5-8. PubMed ID: 11516561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of apoE-epsilon4 in Alzheimer's disease is age dependent.
    Frisoni GB; Manfredi M; Geroldi C; Binetti G; Zanetti O; Bianchetti A; Trabucchi M
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):103-6. PubMed ID: 9667569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
    Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
    Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic Downregulation of APOE, Polymorphic Variations of APOE, Diet, Social Isolation, and Co-morbidities as Contributing Factors to Alzheimer's Disease: a Case-Control Study of Kashmiri Population.
    Nissar K; Firdous P; Hussain A; Bashir S; Ahmad Z; Ganai BA
    Mol Neurobiol; 2023 Oct; 60(10):5891-5901. PubMed ID: 37357229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
    Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
    Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
    Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
    Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.